What causes blood to be dark and thick?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Causes Blood to Be Dark and Thick

Blood becomes dark and thick primarily due to increased red blood cell mass (polycythemia/erythrocytosis), which elevates blood viscosity and reduces oxygen saturation, making the blood appear darker. 1

Primary Mechanisms

Increased Red Blood Cell Production (Erythrocytosis)

The most common cause of thick blood is increased red cell mass, which directly increases blood viscosity. 2, 3 This occurs through two main pathways:

  • Compensatory erythrocytosis: In cyanotic conditions (like congenital heart disease with right-to-left shunting), chronic hypoxemia triggers the kidneys to release erythropoietin, stimulating bone marrow to produce more red blood cells in an attempt to improve tissue oxygenation 1
  • Primary polycythemia vera: A clonal myeloproliferative disorder where bone marrow overproduces red blood cells independent of oxygen needs 1, 3

Why Blood Appears Dark

Blood appears darker when it contains more deoxygenated hemoglobin. 1 Specifically:

  • Arterial oxygen saturations below 75% result in visible cyanosis and darker blood color 1
  • Increased quantities of reduced (deoxygenated) hemoglobin greater than 5 g/100 mL blood cause central cyanosis 1
  • Right-to-left shunting in cyanotic heart disease results in low systemic arterial oxygen saturation, producing darker blood 1

Secondary Factors That Worsen Blood Thickness

Iron Deficiency Paradox

Iron deficiency actually worsens blood viscosity despite causing anemia. 1, 4 This occurs because:

  • Iron-deficient red cells become rigid, microcytic microspheres (8 μm diameter) that are less deformable in capillaries (4-6 μm diameter) 1
  • These rigid cells increase resistance to flow in the microcirculation, paradoxically worsening hyperviscosity symptoms 1, 4
  • Iron deficiency is the strongest independent predictor of cerebrovascular events—not the hematocrit level itself 4, 5

Plasma Composition Changes

Blood viscosity increases through elevated acute phase reactants and abnormal proteins: 6

  • Increased fibrinogen and other coagulation proteins 1
  • Hypergammaglobulinemia in inflammatory states 6
  • Decreased fibrinolytic activity and increased plasminogen activator inhibitor 1

Clinical Conditions Causing Dark, Thick Blood

Cyanotic Congenital Heart Disease

This represents the classic scenario of both dark AND thick blood: 1

  • Right-to-left shunting causes arterial hypoxemia (dark blood) 1
  • Compensatory erythrocytosis increases hematocrit to 65% or higher (thick blood) 1
  • Decompensated erythrocytosis occurs when aortic oxygen saturations fall below 75% 1

Polycythemia Vera

A primary bone marrow disorder causing excessive red cell production: 1, 3

  • Hemoglobin exceeds 18.5 g/dL in men or 16.5 g/dL in women 7
  • JAK2 mutation present in up to 97% of cases 7
  • Blood viscosity can reach twice normal values, causing vascular occlusions 8

Secondary Polycythemia

Chronic hypoxic conditions stimulate erythropoietin production: 7

  • Chronic obstructive pulmonary disease (COPD) 7
  • Obstructive sleep apnea producing nocturnal hypoxemia 7
  • Smoker's polycythemia from chronic carbon monoxide exposure 7
  • High altitude residence (physiologic adaptation) 7

Dangerous Consequences of Thick, Dark Blood

Thrombotic Complications

Hyperviscosity is the major factor in thrombogenesis: 2, 8

  • Cerebrovascular accidents (stroke) 5, 2, 8
  • Myocardial infarction 5, 2, 8
  • Deep vein thrombosis and pulmonary embolism 2
  • Laminated thrombi in pulmonary arteries (up to 30% of cyanotic patients) 1, 5

Paradoxical Bleeding

Despite thick blood, patients face hemorrhagic complications: 1, 5

  • Platelet dysfunction and thrombocytopenia 1
  • Acquired von Willebrand disease (in over one-third of polycythemia vera patients) 1
  • Hemoptysis occurs in up to 100% of Eisenmenger patients 1, 5

Hyperviscosity Symptoms

Clinical manifestations include: 1, 5

  • Headache, faintness, dizziness, fatigue 1, 5
  • Tinnitus, blurred vision 1, 5
  • Paresthesia of fingers, toes, and lips 1, 5
  • Muscle pain and weakness 1, 5

Critical Management Pitfall

Avoid routine phlebotomy—it causes more harm than benefit. 4, 5 Therapeutic phlebotomy should ONLY be performed when: 4

  • Hemoglobin exceeds 20 g/dL AND hematocrit exceeds 65% 4
  • Patient has moderate-to-severe hyperviscosity symptoms 1, 4
  • Dehydration and iron deficiency have been excluded 1, 4
  • Equal volume replacement with normal saline is provided 4

Repeated phlebotomies without meeting these criteria cause iron depletion, which paradoxically increases stroke risk by creating rigid, poorly deformable red cells with reduced oxygen-carrying capacity. 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyperviscosity in polycythemia vera and other red cell abnormalities.

Seminars in thrombosis and hemostasis, 2003

Research

Polycythemia vera.

American family physician, 2004

Guideline

Management of Cyanotic Heart Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Complications of Erythrocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Assessment Protocol for Incidental Erythrocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Rheological study on vascular occlusion and cellular hyperviscosity syndrome in polycythemia vera.

Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society, 1989

Related Questions

What is the appropriate management for a patient with confirmed polycythemia and symptoms concerning for hyperviscosity syndrome?
What is the cause of polycythemia in a 39-year-old male with elevated hemoglobin (hyperglycemia not present, normal Thyroid-Stimulating Hormone (TSH)) and a Body Mass Index (BMI) of 36?
What is the appropriate management for a patient with polycythemia and hyperglycemia?
What is the likely cause of polycythemia in a patient with elevated hemoglobin levels?
What is the management approach for a 26-year-old female with elevated hemoglobin (Hb), hematocrit (Hct), and red blood cell (RBC) count?
What is the recommended dosing for Augmentin (amoxicillin-clavulanate) and topical antibiotic eye drops, such as moxifloxacin (generic) or gatifloxacin (generic), for a child under 5 years old with a dog bite to the eye?
What is the recommended thromboprophylaxis regimen using Lovenox (enoxaparin) in critically ill patients in the Intensive Care Unit (ICU)?
What is the normal range for Mean Platelet Volume (MPV) on a Complete Blood Count (CBC) and what conditions can cause it to be elevated or decreased?
What is the best course of action for a patient with a history of difficult venous access or high risk of infection, who develops a knot in their intravenous (IV) line in a hospital setting?
What are the potential causes and treatment options for a patient with forearm, shoulder, and neck pain, considering factors such as age, occupation, and underlying medical conditions like arthritis or fibromyalgia?
What could be the underlying cause of a young individual frequently changing cars and not focusing on their studies, exhibiting impulsive behavior?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.